The targeted drug delivery system will enable us to administer drugs to women for the treatment of preterm labour, that previously were unable to be administered to women due to affects on other organs. Our approach utilises liposomes, a kind of organic nanoparticle capable of carrying a drug payload, that we have now modified in order to target the liposomes specifically to a marker expressed on the uterine tissue.
Premature birth is the most common reason for a newborn baby to die. Unfortunately, current treatments for premature birth are not very effective. We have developed a mechanism for targeting the delivery of drugs to the uterine tissue, which we believe can be used to prevent or block preterm labour.